[ Price : $8.95]
FDA proposes eliminating CFCs in OTC epinephrine metered-dose inhalers.[ Price : $8.95]
FDAs Circulatory System Devices Advisory Panel recommends FDA approve SyntheMeds Repel-CV for pediatric use.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on Quality System Regulations for medical devices.[ Price : $8.95]
Federal Register Notice: FDA plans a series of educational workshops on quality pharmaceutical production under current good manuf...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to remove the essential-use designation for epinephrine used in oral pressurized mete...[ Price : $8.95]
The Senate passes unanimously the FDA Amendments Act 9/20 after Richard Burr (R-NC) drops a hold he'd placed on it in opposition t...[ Price : $8.95]
An American University survey says consumers trust FDA more than any other organization on prescription drug issues but arent sure...[ Price : $8.95]
Purdue Pharma pays $160 million to the federal government and several states to settle charges of improperly marketing OxyContin o...